Table 3 Clinical outcomes
pRIFLE | KDIGO | pROCK | ||||
|---|---|---|---|---|---|---|
Non-AKI (n = 228) | AKI (n = 185) | Non-AKI (n = 253) | AKI (n = 160) | Non-AKI (n = 336) | AKI (n = 77) | |
MV duration (hour) | 11 (6–25) | 19 (7–26.5) | 11 (6–25) | 19 (7–26.5)* | 11 (6–24) | 24 (9–50) † |
Prolonged MV | 22 (9.6%) | 19 (10.3%) | 24 (9.5%) | 17 (10.6%) | 24 (7.1%) | 17 (22.1%)† |
PICU LOS (day) | 3.5 (2–5) | 3 (1–5) | 3 (2–5) | 3 (2–5) | 3 (2–5) | 5 (3–8) † |
Prolonged PICU stay | 20 (8.8%) | 21 (11.4%) | 23 (9.1%) | 18 (11.3%) | 27 (8.0%) | 14 (18.2%)** |
Hospital LOS (day) | 13 (10–17) | 13 (10–17) | 13 (10–17) | 13 (10–17) | 13 (10–17) | 15 (11–21)** |
Composite outcome | 14 (6.1%) | 17 (9.2%) | 18 (7.1%) | 13 (8.1%) | 18 (5.4%) | 13 (16.9%)** |
Peritoneal dialysis | 4 (1.8%) | 3 (1.6%) | 4 (1.6%) | 3 (1.9%) | 4 (1.2%) | 3 (3.9%) |
Re-operation | 5 (2.2%) | 4 (2.2%) | 5 (2.0%) | 4 (2.5%) | 5 (1.5%) | 4 (5.2%) |
Re-intubation | 4 (1.8%) | 5 (2.7%) | 6 (2.4%) | 3 (1.9%) | 6 (1.8%) | 3 (3.9%) |
Pulmonary infection | 9 (3.9%) | 13 (7.0%) | 11 (4.3%) | 11 (6.9%) | 11 (3.3%) | 11 (14.3%)† |
ECMO | 2 (0.9%) | 1 (0.5%) | 2 (0.8%) | 1 (0.6%) | 2 (0.6%) | 1 (1.3%) |
Mortality | 0 | 1 (0.5%) | 0 | 1 (0.6%) | 0 | 1 (1.3%) |